Acasti Pharma (ACST) Q2 2024 Earnings

Jun 21Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.54
-0.39
-0.24
-0.09

Details

Expected EPS
-0.35
Actual EPS
-0.17
Surprise EPS
0.18
Surprise Percent
+51.43%

Description

⁨Acasti Pharma⁩ (⁦ACST⁩) has reported earnings of ⁦-0.17⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts